A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma - Regional Cancer Care Associates LLC

Clinical Trials

A Clinical Study to Demonstrate Safety and Efficacy of E7777 (Denileukin Diftitox) in Persistent or Recurrent Cutaneous T-Cell Lymphoma

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Eisai
Protocol Number
E7777-G000-302
Cancer Diagnosis
To Learn More Call
201-510-0910